Dieckmann-Schuppert A, Bender S, Odenthal-Schnittler M, Bause E, Schwarz R T
Zentrum für Hygiene und Medizinische Mikrobiologie, University of Marburg, Federal Republic of Germany.
Eur J Biochem. 1992 Apr 15;205(2):815-25. doi: 10.1111/j.1432-1033.1992.tb16846.x.
This study investigates protein glycosylation in the asexual intraerythrocytic stage of the malaria parasite, Plasmodium falciparum, and the presence in the infected erythrocyte of the respective precursors. In in vitro cultures, P. falciparum can be metabolically labeled with radioactive sugars, and its multiplication can be affected by glycosylation inhibitors, suggesting the capability of the parasite to perform protein-glycosylation reactions. Gel-filtration analysis of sugar-labeled malarial proteins before and after specific cleavage of N-glycans or O-glycans, respectively, revealed the majority of the protein-bound sugar label to be incorporated into O-glycans, but only little (7-12% of the glucosamine label) or no N-glycans were found. Analysis of the nucleotide sugar and sugar-phosphate fraction showed that radioactive galactose, glucosamine, fucose and ethanolamine were converted to their activated derivatives required for incorporation into protein. Mannose was mainly recovered as a bisphosphate, whereas the level of radiolabeled GDP-mannose was below the detection limit. The analysis of organic-solvent extracts of sugar-labeled cultures showed no evidence for the formation by the parasite of dolichol cycle intermediates, the dedicated precursors in protein N-glycosylation. Consistently, the amount of UDP-N-acetylglucosamine formed did not seem to be affected by the presence of tunicamycin in the culture. Oligosaccharyl-transferase activity was not detectable in a lysate of P. falciparum, using exogenous glycosyl donors and acceptors. Our studies show that O-glycosylation is the major form of protein glycosylation in intraerythrocytic P. falciparum, whereas there is little or no protein N-glycosylation. A part of these studies has been published in abstract form [Dieckmann-Schuppert, A., Hensel, J. and Schwarz, R. T. (1991) Biol. Chem. Hoppe-Seyler 372, 645].
本研究调查了疟原虫恶性疟原虫无性红细胞内期的蛋白质糖基化情况,以及感染红细胞中相应前体的存在情况。在体外培养中,恶性疟原虫可用放射性糖进行代谢标记,其增殖可受糖基化抑制剂影响,这表明该寄生虫具有进行蛋白质糖基化反应的能力。分别对N-聚糖或O-聚糖特异性切割前后的糖标记疟原虫蛋白进行凝胶过滤分析,结果显示与蛋白结合的糖标记大部分掺入了O-聚糖,但仅发现少量(占氨基葡萄糖标记的7 - 12%)或未发现N-聚糖。对核苷酸糖和糖磷酸部分的分析表明,放射性半乳糖、氨基葡萄糖、岩藻糖和乙醇胺被转化为掺入蛋白质所需的活化衍生物。甘露糖主要以双磷酸形式回收,而放射性标记的GDP-甘露糖水平低于检测限。对糖标记培养物的有机溶剂提取物分析未发现该寄生虫形成多萜醇循环中间体(蛋白质N-糖基化的专用前体)的证据。同样地,培养物中存在衣霉素似乎并未影响UDP-N-乙酰氨基葡萄糖的形成量。使用外源性糖基供体和受体时,在恶性疟原虫裂解物中未检测到寡糖基转移酶活性。我们的研究表明,O-糖基化是恶性疟原虫红细胞内期蛋白质糖基化的主要形式,而蛋白质N-糖基化很少或不存在。这些研究的一部分已以摘要形式发表[Dieckmann-Schuppert, A., Hensel, J. and Schwarz, R. T. (1991) Biol. Chem. Hoppe-Seyler 372, 645]。